Mittra A, Coyne GHOS, Zlott J, Kummar S, et al. Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors. Cancer Chemother Pharmacol 2024;93:177-189.
PMID: 38010394